Toll-Like receptor 3 genetic polymorphism in dengue encephalitis

Rajesh Verma1, Atul K Pandey2, Rajarshi Chakraborty1

  • 1Department of Neurology, King George's Medical University, Lucknow, Uttar Pradesh, India.

Abstract

Insights

The Toll-like receptor 3 (TLR3) Leu412Phe polymorphism is associated with an increased risk of dengue encephalitis. This TLR3 gene variant did not impact mortality outcomes in dengue patients.

Area of Science:

  • Immunology
  • Genetics
  • Infectious Diseases

Background:

  • Dengue is a significant vector-borne viral illness with varied human manifestations.
  • Toll-like receptors (TLRs) are crucial for innate immunity against pathogens.
  • TLR3 plays a key role in the immune response to flaviviruses like dengue.

Purpose of the Study:

  • To investigate the association between TLR3 gene single nucleotide polymorphism (SNP) and dengue encephalitis (DE).
  • To analyze genotype, allele, and haplotype distributions of TLR3 Leu412Phe polymorphism in DE patients.
  • To determine the correlation between TLR3 polymorphism and clinical outcomes, including mortality.

Main Methods:

  • A case-controlled observational study was conducted.
  • Real-time polymerase chain reaction (PCR) was used to genotype the TLR3 Leu412Phe SNP.
  • 29 DE patients were compared with 29 age- and sex-matched dengue patients without neurological complications.

Main Results:

  • The mutant genotype Phe/Phe (TT) of TLR3 Leu412Phe polymorphism showed a significant association with DE (31.03% vs 6.8%, P=0.019).
  • No statistically significant association was found for the heterozygous genotype (Leu/Phe-CT) or the mutant Phe allele (T).
  • TLR3 gene polymorphism did not correlate with 1-month mortality outcomes.

Conclusions:

  • The mutant TLR3 Leu412Phe polymorphism may increase susceptibility to DE in dengue-infected individuals within the Indian population.
  • TLR3 polymorphism does not appear to influence mortality at one month post-infection.